Glenmark becomes the first company to launch Remogliflozin V

Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed-dose combination (FDC) of its novel, patent-prote

Related Keywords

Mumbai , Maharashtra , India , Remogliflozin Etabonate , Alok Malik , Glenmark Remogliflozin Vildagliptin , Group Vice Presidentbusiness Head , Glenmark Pharmaceuticals Limited , Glucose Co , International Diabetes Federation , Sodium Glucose Co Transporter Inhibitor , Dipeptidyl Peptidase , Remogliflozin Vildagliptin Metformin , Fixed Dose Combination , Textiles News , Launch , Khan The , Has Been , Mprove Glycemic , Vildagliptin , Pp4 Inhibitor , India For , Aunched , Ono Components ,